Phio Pharmaceuticals Corp. - 8-K Filing

Phio Pharmaceuticals appoints R. Todd Plott, M.D. to its Board effective July 20, 2026 (Items: 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Offi, 8.01 Other Events, 9.01 Financial Statements and Exhibits)

SEC EDGAR ·

Tickers: $PHIO

Read the full article at SEC EDGAR

More Regulatory news